Call us at
+94 112 421 836
Email us at
info@celogen.lk
Established in 2016, Celogen Group has grown into a leading pharmaceutical conglomerate in Sri Lanka, providing high-quality healthcare solutions to hospitals and clinics nationwide. Celogen Lanka, the Group's solid dosage finished formulation manufacturing segment, operates a state-of-the-art EU-GMP approved facility equipped with advanced machinery and instruments. The facility is also certified by WHOGMP/cGMP NMRA* Sri Lanka, ensuring excellence in pharmaceutical manufacturing.
Celogen Lanka is the first Joint Venture partner under the patronage and guidance of the State Pharmaceuticals Manufacturing Corporation of Sri Lanka (SPMC) considering international product quality standards for the domestic market.
Celogen Lanka specializes in manufacturing and marketing more than 650+ different products including Tablets (uncoated / film-coated / extended-release / sustained-release / prolongedrelease / dispersible), Hard Gelatin Capsules (powder / pellets / extended-release pellets), Soft Gelatin Capsules, Suppositories / Pessaries, and Sachets.** Our product portfolio caters to many therapeutic segments such as Cardiovascular, Anti-diabetic, Anti-infectives, Gastrointestinal, Nephrology, Central Nervous System, NSAIDs, Family care, Vitamins, Cosmetology, and more.
The accelerated growth of the company is attributed to a dedicated team of more than 500 employees including scientists, pharmaceutical experts, and proficient management professionals who are further backed by highly equipped R&D facilities and modern technology.
Celogen Lanka is always committed to providing effective and quality healthcare solutions at affordable prices, enabling people to lead healthier lives.
We care deeply for life and continue to espouse the
health benefits to people by manufacturing & supplying
international standard quality medicines at affordable
prices.
Our Purpose
We seek to touch lives every day by providing highquality healthcare products to enrich the lives of our customers, their families, and our stakeholders to support the Earth's most precious resource – human lives.
Inception
In 2016, Celogen Lanka was established to boost the supply of quality medicines to domestic & export markets such as South East Asia, CIS, Middle East, Latin America, and Europe.
R & D Support
Celogen Lanka is backed by Research & Development support from:
- Celogen Pharma, Maharashtra, India (EU-GMPapproved)
- Kelun Group,
China
Sichuan Kelun Pharmaceutical Research Institute, Chengdu
Suzhou Kelun Pharmaceutical Research Co. Ltd, Suzhou
Tianjin Kelun Pharmaceutical Research Co. Ltd, Tianjin - KLUS Pharma, New Jersey, USA
- Zydus Research Zydus Research Centre, Gujarat, India (USFDA& EU-GMP approved)
Why Us?
Celogen Lanka is the largest pharmaceutical manufacturer of solid dosage finished formulations in Sri Lanka, with a widespread domestic presence and a growing international footprint. We are the first and only EU-GMP approved manufacturing facility for oral solid dosage forms in Sri Lanka, setting new industry benchmarks for quality and compliance.
We are one of the leading finished formulation pharmaceutical suppliers to the Government of Sri Lanka under the patronage of the State Pharmaceuticals Manufacturing Corporation of Sri Lanka (SPMC). We also manufacture various domestic and international brands for Zydus Lifesciences, India.
Our focus has always been on Novel Drug Delivery Systems (NDDS) in response to emerging market trends, which benefit patients in terms of better comfort and efficacy.
We have a world-class facility where we are fully committed to providing the best quality products with a consistent supply.
Celogen Lanka is a key member of one of Sri Lanka's largest pharmaceutical manufacturing group.
Regulatory Approvals
We have more than 650+ products with 855+ SKUs in our current portfolio and will be expanding it by adding new molecules, including new therapeutic ranges and dosage forms. This comprehensive range of medicines provides various benefits in the treatment of chronic and acute diseases in human beings. Our regulatory team controls strategic and operational frameworks by working with updated regulatory guidelines. Their rich experience ascertains that the drug development team adheres to regulatory compliances.
We have a fully equipped in-house laboratory accredited by SLAB*** ISO 17025:2017, equipped with HPLCs, ICP, UV Spectrometer, Gas Chromatography, FTIR and Stability chambers, which gives us the strength to test and maintain the quality standards of our products..
Our manufacturing setup is equipped with machines and instruments of international standards. We have implemented the SAP system and follow GDP (Good Documentation Practices) as per WHO-GMP guidelines.
Celogen Lanka is periodically assessed by regulators to maintain the compliance with EU-GMP, WHO GMP/cGMP NMRA Sri Lanka guidelines and is also certified under PIC/S, ISO 9001:2015, ISO 14001:2015, ISO 22000:2018, and ISO 45001:2018. These approvals and certifications enable us to consistently manufacture, market, and distribute high quality products.
Following the successful achievement of EU-GMP accreditation, we are in the process of obtaining regulatory approvals from TGA (Australia), TPD (Health Canada), ANVISA (Brazil) and EAEU-GMP. This further reinforces our commitment to delivering globally recognized, high-quality pharmaceuticals. Our robust Quality Management System (QMS) and world-class operating procedures ensure that every product meets stringent international regulatory and safety standards.
